Veradermics reports positive Phase 2/3 trial results for hair loss drug

April 27, 2026 7:00 AM

Veradermics Inc. (NYSE: MANE) announced that its oral hair loss treatment VDPHL01 met all primary and secondary endpoints in a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found